Cancer: A Problem of Developmental Biology; Scientific Evidence for Reprogramming and Differentiation Therapy

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|17|10|1103-1110

ISSN： 1389-4501

Source： Current Drug Targets, Vol.17, Iss.10, 2016-08, pp. : 1103-1110

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cancer Cell Reprogramming: Stem Cell Differentiation Stage Factors and An Agent Based Model to Optimize Cancer Treatment

By  

Current Pharmaceutical Biotechnology, Vol. 12, Iss. 2, 2011-02 ,pp. : 231-242

Bentham Science Publishers

Access to resources Recommend Favorite

Totipotency, cell differentiation and reprogramming in humans

By Hansis Christoph  

Reproductive BioMedicine Online, Vol. 13, Iss. 4, 2006-10 ,pp. : 551-557

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Reactive Oxygen Species in Cancer Biology and Anticancer Therapy

By  

Current Medicinal Chemistry, Vol. 20, Iss. 30, 2013-10 ,pp. : 3677-3692

Bentham Science Publishers

Access to resources Recommend Favorite

Mitochondrial dynamics: biology and therapy in lung cancer

By Lennon Frances E   Salgia Ravi  

Expert Opinion on Investigational Drugs, Vol. 23, Iss. 5, 2014-05 ,pp. : 675-692

Informa Healthcare

Access to resources Recommend Favorite

Role of PARP Inhibitors in Cancer Biology and Therapy

By  

Current Medicinal Chemistry, Vol. 19, Iss. 23, 2012-08 ,pp. : 3907-3921

Bentham Science Publishers

Access to resources Recommend Favorite